Study Details
Full Title
CONNECT1905: Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma
Principal Investigator
Daniel
Landi
Protocol Number
PRO00113161
NCT ID
NCT05233397
Phase
II
Enrollment Status
Open to Enrollment